Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism

• Autores principales: Linjie Pan (Autor), Zhanchi Xu (Autor), Min Wen (Autor), Minghui Li (Autor), Dongxin Lyu (Autor), Haiming Xiao (Autor), Zhuoming Li (Autor), Junhui Xiao (Autor), Yuanyuan Cheng (Autor), Heqing Huang (Autor)
• Formato: Libro
• Publicado: BMC, 2024-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Abstract Background Heart failure (HF) is characterized by a disorder of cardiomyocyte energy metabolism. Xinbao Pill (XBW), a traditional Chinese medicine formulation integrating "Liushen Pill" and "Shenfu Decoction," has been approved by China Food and Drug Administration for t...